Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
AstraZeneca, Wilmington, Delaware.
Am J Cardiol. 2021 Jul 15;151:70-77. doi: 10.1016/j.amjcard.2021.04.019. Epub 2021 May 27.
Heart failure (HF) is common in patients presenting with acute myocardial infarction (MI), but incidence and predictors of new onset HF after hospitalization for MI are less well characterized. We evaluated patients hospitalized for acute MI without preceding or concurrent HF in the National Cardiovascular Data Registry (NCDR) CathPCI and Chest Pain-MI registries linked with claims data between April 2010 and March 2017. Cumulative incidence and independent predictors of HF after discharge were determined, and a simplified risk score was developed to predict incident HF following MI. In 337,274 patients with acute MI and no history of HF, 8.0% developed incident HF within 1 year after discharge and 18.8% developed HF within 5 years. Significant predictors of HF after MI included advanced chronic kidney disease (CKD) (HR 2.34, 95% confidence interval [CI] 2.23-2.46 for Stage IV vs Stage I, and HR 2.18, 95% CI 2.07-2.29 for Stage V vs. Stage I), recurrent MI following index MI (HR 2.24, 95% CI 2.19-2.28), African-American race (HR 1.44, 95% CI 1.40-1.48), and diabetes (HR 1.39, 95% CI 1.37-1.42). A risk score of 8 variables predicted HF with modest discrimination (optimism-corrected c-statistic 0.64) and good calibration. In conclusion, nearly 1 in 5 patients in a large nationally representative cohort without preceding or concurrent heart failure at time of MI developed incident HF within 5 years after discharge. Advanced CKD and recurrent MI were the strongest predictors of future HF. Increased recognition of specific risk factors for HF may help inform care strategies following MI.
心力衰竭(HF)在急性心肌梗死(MI)患者中很常见,但MI 住院后新发 HF 的发生率和预测因素尚不清楚。我们评估了 2010 年 4 月至 2017 年 3 月期间国家心血管数据注册(NCDR)CathPCI 和胸痛-MI 登记处与索赔数据链接的没有先前或并发 HF 的急性 MI 住院患者。确定了出院后 HF 的累积发生率和独立预测因素,并开发了一个简化的风险评分来预测 MI 后发生 HF。在 337274 例无 HF 既往史的急性 MI 患者中,有 8.0%的患者在出院后 1 年内发生了新发 HF,18.8%的患者在 5 年内发生了 HF。MI 后 HF 的显著预测因素包括晚期慢性肾脏病(CKD)(HR 2.34,95%置信区间[CI]2.23-2.46 为 IV 期与 I 期,HR 2.18,95%CI 2.07-2.29 为 V 期与 I 期)、指数 MI 后复发性 MI(HR 2.24,95%CI 2.19-2.28)、非裔美国人种族(HR 1.44,95%CI 1.40-1.48)和糖尿病(HR 1.39,95%CI 1.37-1.42)。一个包含 8 个变量的风险评分对 HF 具有适度的鉴别力(校正后的乐观 c 统计量为 0.64)和良好的校准度。总之,在一个大型的全国代表性队列中,近五分之一的患者在 MI 时没有先前或并发心力衰竭,但在出院后 5 年内发生了新发 HF。晚期 CKD 和复发性 MI 是未来 HF 的最强预测因素。对 HF 特定危险因素的认识增加可能有助于为 MI 后的护理策略提供信息。